Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level
In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC
NCI Programs: BSA Approves Formation Of Two Grant Programs:
Molecular target Drug Discovery Grants; Unanimously Approved
Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote
DO RFAs cut Into R01 Grant Pool? Board Asks
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- White House announces “TrumpRx,” a new prescription drug website
- The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.” - Lazarex Cancer Foundation set to close its doors Dec. 31
Can health nonprofits survive in the current environment?